Sling Insertion Angle and Outcomes in Single-Incision Midurethral Sling Surgery
SUI-SLING
Effect of Sling Insertion Angle on Surgical Outcomes and Quality of Life Following Single-Incision Midurethral Sling Surgery for Stress Urinary Incontinence
1 other identifier
observational
184
1 country
1
Brief Summary
This study aims to evaluate the effect of sling insertion angle on surgical outcomes and quality of life in women with stress urinary incontinence (SUI) undergoing single-incision midurethral sling surgery. Women diagnosed with urodynamic stress urinary incontinence who underwent surgery using a single-incision sling system were included. Patients were categorized into two groups based on sling insertion angle: an acute-angle group (\<45°, resembling a retropubic trajectory) and a standard-angle group (approximately 45°, toward the obturator foramen). The primary outcome was objective cure at 6 months, defined as a negative cough stress test without the need for additional anti-incontinence treatment. Secondary outcomes included objective cure at 1 and 3 months, postoperative voiding difficulty, persistent SUI symptoms, and quality of life assessed using the Incontinence Quality of Life (I-QOL) questionnaire. This study provides clinical evidence on whether sling insertion angle influences early and mid-term outcomes following single-incision midurethral sling surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2017
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2019
CompletedFirst Submitted
Initial submission to the registry
April 8, 2026
CompletedFirst Posted
Study publicly available on registry
April 15, 2026
CompletedApril 15, 2026
April 1, 2026
2.1 years
April 8, 2026
April 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Objective cure rate at 6 months
Objective cure is defined as a negative cough stress test and no requirement for additional anti-incontinence treatment at 6 months after surgery.
6 months after surgery
Secondary Outcomes (4)
Objective cure rate at 1 and 3 months
1 month and 3 months
Postoperative voiding difficulty
Within 6 months after surgery
Persistent stress urinary incontinence symptoms
Up to 6 months
Quality of life measured by I-QOL score
6 months
Study Arms (2)
Acute-angle sling group (<45°)
Participants undergoing single-incision midurethral sling surgery with a sling insertion angle of less than 45 degrees, corresponding to a retropubic, TVT-like trajectory. This approach is hypothesized to provide earlier urethral support and improved early continence outcomes.
Standard-angle sling group (≈45°)
Participants undergoing single-incision midurethral sling surgery with a standard sling insertion angle of approximately 45 degrees toward the obturator foramen. This represents the conventional transobturator-oriented trajectory used in routine clinical practice.
Eligibility Criteria
Adult female patients diagnosed with urodynamic stress urinary incontinence who underwent single-incision midurethral sling surgery at a tertiary medical center. All procedures were performed by a single experienced surgeon, and patients had available follow-up data for at least 6 months.
You may qualify if:
- Female patients aged 18 years or older
- Diagnosis of urodynamic stress urinary incontinence (SUI)
- Preoperative 1-hour pad test \>10 g
- Undergoing single-incision midurethral sling surgery (ContaSure Needleless system)
- Availability of complete clinical and follow-up data for at least 6 months
You may not qualify if:
- Presence of detrusor overactivity on urodynamic study
- Mixed urinary incontinence with predominant urge symptoms
- Voiding dysfunction
- History of prior pelvic or anti-incontinence surgery
- Neurological disorders affecting lower urinary tract function
- Pelvic organ prolapse stage ≥ III (POP-Q classification)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Shin Kong Wu Ho-Su Memorial Hospital
Taipei, Taiwan, 111, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, Department of Obstetrics and Gynecology, Shin Kong Wu Ho-Su Memorial Hospital
Study Record Dates
First Submitted
April 8, 2026
First Posted
April 15, 2026
Study Start
October 1, 2017
Primary Completion
October 31, 2019
Study Completion
October 31, 2019
Last Updated
April 15, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared due to patient privacy concerns and institutional restrictions. The data contain potentially identifiable clinical information, and sharing is not permitted under the approval of the Institutional Review Board. De-identified data may be available from the corresponding author upon reasonable request and with appropriate institutional approvals.